{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:42:26Z","timestamp":1792057346776,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mayocp.2021.01.028","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T19:14:26Z","timestamp":1617304466000},"page":"1033-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients"],"prefix":"10.1016","volume":"96","author":[{"given":"Elizabeth A.","family":"Gilman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-4542","authenticated-orcid":false,"given":"Sandhya","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin W.","family":"Hofstatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Mussallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mayocp.2021.01.028_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.028_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-011-1853-z","article-title":"Risk prediction models of breast cancer: a systematic review of model performances","volume":"133","author":"Anothaisintawee","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.mayocp.2021.01.028_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.mayocp.2021.01.028_bib5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.028_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.rcl.2016.12.013","article-title":"Breast cancer risk assessment models and high-risk screening","volume":"55","author":"Barke","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.028_bib7","first-page":"967","article-title":"Review of non-clinical risk models to aid prevention of breast cancer","volume":"29","author":"Al-Ajmi","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"22","key":"10.1016\/j.mayocp.2021.01.028_bib8","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","article-title":"Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia","volume":"28","author":"Boughey","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"15 suppl","key":"10.1016\/j.mayocp.2021.01.028_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1200\/JCO.2020.38.15_suppl.1503","article-title":"Performance of the IBIS\/Tyrer-Cuzick (TC) Model by race\/ethnicity in the Women\u2019s Health Initiative","volume":"38","author":"Kurian","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"10.1016\/j.mayocp.2021.01.028_bib10","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO Clinical Practice Guideline Update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.028_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2014risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.mayocp.2021.01.028_bib12","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo cohort study","volume":"25","author":"Degnim","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.mayocp.2021.01.028_bib13","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/cncr.30153","article-title":"Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women","volume":"122","author":"Degnim","year":"2016","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.mayocp.2021.01.028_bib14","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2021.01.028_bib15","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.breast.2017.06.027","article-title":"Preventing invasive breast cancer using endocrine therapy","volume":"34","author":"Thorat","year":"2017","journal-title":"Breast"},{"issue":"22","key":"10.1016\/j.mayocp.2021.01.028_bib16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.mayocp.2021.01.028_bib17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.mayocp.2021.01.028_bib18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.028_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial","volume":"99","author":"Powles","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.028_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.6004\/jnccn.2010.0086","article-title":"Nonhormonal management of hot flashes for women on risk reduction therapy","volume":"8","author":"Sideras","year":"2010","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"23","key":"10.1016\/j.mayocp.2021.01.028_bib21","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial [published corrections appear in JAMA. 2006;296(24):2926 and JAMA. 2007;298(9):973]","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.mayocp.2021.01.028_bib22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.028_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-20-3609","article-title":"A\u00a0randomized phase IIb study of low-dose tamoxifen in chest-irradiated cancer survivors at risk for breast cancer","volume":"27","author":"Bhatia","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"25","key":"10.1016\/j.mayocp.2021.01.028_bib24","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women [published correction appears in N Engl J Med. 2011;365(14):1361]","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9922","key":"10.1016\/j.mayocp.2021.01.028_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial [published corrections appear in Lancet. 2014;383(9922):1040 and Lancet. 2017;389(10073):1010]","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2021.01.028_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ctrv.2016.11.012","article-title":"Management of hot flashes in women with breast cancer receiving ovarian function suppression","volume":"52","author":"Leon-Ferre","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.028_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"31","key":"10.1016\/j.mayocp.2021.01.028_bib28","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.2015.60.9412","article-title":"Electroacupuncture versus gabapentin for hot flashes among breast cancer survivors: a randomized placebo-controlled trial","volume":"33","author":"Mao","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.028_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator","volume":"8","author":"Wills","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.028_bib30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","article-title":"Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors","volume":"33","author":"Irwin","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.028_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2018.8907","article-title":"Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial","volume":"320","author":"Hershman","year":"2018","journal-title":"JAMA"},{"issue":"31","key":"10.1016\/j.mayocp.2021.01.028_bib32","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO Clinical Practice Guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2021.01.028_bib33","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/oby.2009.18","article-title":"Exercise improves body fat, lean mass, and bone mass in breast cancer survivors","volume":"17","author":"Irwin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.028_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/oby.21729","article-title":"The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors","volume":"25","author":"Thomas","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.028_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"15 suppl","key":"10.1016\/j.mayocp.2021.01.028_bib36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2019.37.15_suppl.1501","article-title":"Impact of a breast cancer (BC) polygenic risk score (PRS) on the decision to take preventive endocrine therapy (ET): the Genetic Risk Estimate (GENRE) trial","volume":"37","author":"Kim","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621001385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621001385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:34:41Z","timestamp":1758418481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621001385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0025619621001385"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.028","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing Breast Cancer Through Identification and Pharmacologic Management of High-Risk Patients","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}